Obamacare enrollment declines as US subsidies expire

ACA enrollment fell to about 15.6 million for 2026 from roughly 16 million a year earlier as pandemic-era federal subsidies are set to expire on Dec. 31, driving projected average annual premiums for subsidized plans to $1,904 in 2026 versus $888 in 2025. The subsidy lapse leaves roughly 24 million Americans exposed to steep cost increases, a KFF poll found 25% would forgo coverage if premiums doubled, and CMS attributed part of the enrollment decline to efforts to curb fraudulent sign-ups, heightening downside risk to insurer revenues and coverage rates ahead of the Jan. 15 sign-up deadline.

Analysis

Market structure: The expiration of enhanced ACA subsidies materially re-prices the individual-market risk pool — direct losers are pure-play marketplace carriers and state exchange market share (Centene CNC, Molina MOH more exposed) while large diversified payors (UnitedHealth UNH, Elevance ELV, CVS CVS via Aetna) have greater pricing and product flexibility to offset enrollment declines. Premiums set to more than double (average ~$1,904 vs $888) compress demand: expect 15–25% enrollee attrition in affected cohorts in 1H26, concentrating sicker lives and raising loss ratios for narrow-network ACA books.

Risk assessment: Near term (days–weeks) watch enrollment flow through Jan 15; short-term (Q1–Q2 2026) earnings will reveal morbidity mix and reserve adjustments; long-term (2026–2028) political risk — Congress could reinstate subsidies or states may expand Medicaid/reinsurance, reversing impacts. Tail risks include sudden federal intervention (positive for ACA names) or large-scale litigation/state emergency plans increasing cost volatility; hidden dependencies include state budgets and hospital uncompensated-care burdens that feed muni-credit stress.

Trade implications: Favor large, vertically integrated insurers and PBMs as defensive longs (UNH, ELV, CVS) and short concentrated ACA exposure (CNC, MOH) via equity or put structures; consider buying 3–9 month puts on MOH/CNC 10–15% OTM and selling covered calls on UNH/ELV to enhance yield. Rotate away from small regional hospital REITs and high-duration muni-credit with large Medicaid exposure; increase cash/hedge into Jan 15 enrollment print and Q1 earnings.

Contrarian angles: Consensus underestimates speed of political response — a targeted subsidy fix or state reinsurance in H1 2026 would cause a rapid snap-back, making deep OTM puts on diversified insurers a poor hedge but very valuable on pure-play ACA names. Historical parallels (2014 Medicaid churn, 2021 temporary subsidy spike) show enrollment elasticity is high around price shocks; unintended consequence: acute rise in uncompensated care could pressure hospital margins and force consolidation — potential takeover targets among regional hospitals.

Key Decisions for Investors

• Establish a 2–3% long position in UnitedHealth (UNH) and/or Elevance (ELV) over 3–9 months to capture premium pricing power and diversification; average in on any >3% pullback and trim on >10% outperformance.
• Initiate a 1–2% short position in Centene (CNC) and Molina (MOH) combined (equal-weight) via stock or buy 3–6 month puts 10–15% OTM, as their ACA exposure suggests 10–30% downside risk into Q2 2026 earnings if enrollment loss and higher loss ratios materialize.
• Buy protection on municipal/healthcare-credit exposure: reduce high-duration state-muni positions by 20% if holdings concentrated in Medicaid-heavy states (CA, NY, TX) and reallocate to short-duration munis; if a specific muni fund underperforms by >2% vs MUB in 30 days, increase hedges.
• Implement a 3–6 month options income trade: sell covered calls on UNH/ELV (5–10% OTM) to monetize elevated volatility into Jan 15 enrollment print; simultaneously buy MOH/CNC puts as asymmetric downside protection, revisit positions after Jan 15 and Q1 2026 results.